Selected research
Market Structure
Global Amisulpride Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Amisulpride market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Amisulpride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Amisulpride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Amisulpride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Amisulpride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Amisulpride include Sanofi, Qilu Pharma and Vexxa Lifescience, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Amisulpride market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Amisulpride and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Amisulpride sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Amisulpride market size, projected growth trends, production technologies, key applications, and end-use industries.
Amisulpride Segment by Company
Sanofi
Qilu Pharma
Vexxa Lifescience
Amisulpride Segment by Type
50mg/Tablet
400mg/Tablet
200mg/Tablet
Amisulpride Segment by Application
Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
Amisulpride Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amisulpride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Amisulpride and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amisulpride.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Amisulpride market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Amisulpride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Amisulpride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Amisulpride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 50mg/Tablet
- 400mg/Tablet
- 200mg/Tablet
Applications
- Retail Pharmacies
- Online Pharmacies
- Hospital Pharmacies
Companies covered
- Sanofi
- Qilu Pharma
- Vexxa Lifescience
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Amisulpride Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Amisulpride Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Amisulpride Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Amisulpride Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Amisulpride Market Dynamics
- 2.1 Amisulpride Industry Trends
- 2.2 Amisulpride Industry Drivers
- 2.3 Amisulpride Industry Opportunities and Challenges
- 2.4 Amisulpride Industry Restraints
3 Amisulpride Market by Manufacturers
- 3.1 Global Amisulpride Revenue by Manufacturers (2021-2026)
- 3.2 Global Amisulpride Sales by Manufacturers (2021-2026)
- 3.3 Global Amisulpride Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Amisulpride Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Amisulpride Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Amisulpride Manufacturers, Product Type & Application
- 3.7 Global Amisulpride Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Amisulpride Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Amisulpride Players Market Share by Revenue in 2025
- 3.8.3 2025 Amisulpride Tier 1, Tier 2, and Tier 3
4 Amisulpride Market by Type
- 4.1 Amisulpride Type Introduction
- 4.1.1 50mg/Tablet
- 4.1.2 400mg/Tablet
- 4.1.3 200mg/Tablet
- 4.2 Global Amisulpride Sales by Type
- 4.2.1 Global Amisulpride Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Amisulpride Sales by Type (2021-2032)
- 4.2.3 Global Amisulpride Sales Market Share by Type (2021-2032)
- 4.3 Global Amisulpride Revenue by Type
- 4.3.1 Global Amisulpride Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Amisulpride Revenue by Type (2021-2032)
- 4.3.3 Global Amisulpride Revenue Market Share by Type (2021-2032)
5 Amisulpride Market by Application
- 5.1 Amisulpride Application Introduction
- 5.1.1 Retail Pharmacies
- 5.1.2 Online Pharmacies
- 5.1.3 Hospital Pharmacies
- 5.2 Global Amisulpride Sales by Application
- 5.2.1 Global Amisulpride Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Amisulpride Sales by Application (2021-2032)
- 5.2.3 Global Amisulpride Sales Market Share by Application (2021-2032)
- 5.3 Global Amisulpride Revenue by Application
- 5.3.1 Global Amisulpride Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Amisulpride Revenue by Application (2021-2032)
- 5.3.3 Global Amisulpride Revenue Market Share by Application (2021-2032)
6 Global Amisulpride Sales by Region
- 6.1 Global Amisulpride Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Amisulpride Sales by Region (2021-2032)
- 6.2.1 Global Amisulpride Sales by Region (2021-2026)
- 6.2.2 Global Amisulpride Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Amisulpride Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Amisulpride Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Amisulpride Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Amisulpride Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Amisulpride Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Amisulpride Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Amisulpride Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Amisulpride Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Amisulpride Revenue by Region
- 7.1 Global Amisulpride Revenue by Region
- 7.1.1 Global Amisulpride Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Amisulpride Revenue by Region (2021-2026)
- 7.1.3 Global Amisulpride Revenue by Region (2027-2032)
- 7.1.4 Global Amisulpride Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Amisulpride Revenue (2021-2032)
- 7.2.2 North America Amisulpride Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Amisulpride Revenue (2021-2032)
- 7.3.2 Europe Amisulpride Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Amisulpride Revenue (2021-2032)
- 7.4.2 Asia-Pacific Amisulpride Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Amisulpride Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Amisulpride Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Sanofi
- 8.1.1 Sanofi Company Information
- 8.1.2 Sanofi Business Overview
- 8.1.3 Sanofi Amisulpride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Sanofi Amisulpride Product Portfolio
- 8.1.5 Sanofi Recent Developments
- 8.2 Qilu Pharma
- 8.2.1 Qilu Pharma Company Information
- 8.2.2 Qilu Pharma Business Overview
- 8.2.3 Qilu Pharma Amisulpride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Qilu Pharma Amisulpride Product Portfolio
- 8.2.5 Qilu Pharma Recent Developments
- 8.3 Vexxa Lifescience
- 8.3.1 Vexxa Lifescience Company Information
- 8.3.2 Vexxa Lifescience Business Overview
- 8.3.3 Vexxa Lifescience Amisulpride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Vexxa Lifescience Amisulpride Product Portfolio
- 8.3.5 Vexxa Lifescience Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Amisulpride Value Chain Analysis
- 9.1.1 Amisulpride Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Amisulpride Production Mode & Process
- 9.2 Amisulpride Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Amisulpride Distributors
- 9.2.3 Amisulpride Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst